GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orexo AB (OSTO:ORX) » Definitions » Other Long Term Assets

Orexo AB (OSTO:ORX) Other Long Term Assets : kr50.4 Mil (As of Sep. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Orexo AB Other Long Term Assets?

Orexo AB's other long-term assets for the quarter that ended in Sep. 2024 was kr50.4 Mil.

Orexo AB's quarterly other long-term assets increased from Mar. 2024 (kr51.7 Mil) to Jun. 2024 (kr54.0 Mil) but then stayed the same from Jun. 2024 (kr54.0 Mil) to Sep. 2024 (kr50.4 Mil).

Orexo AB's annual other long-term assets declined from Dec. 2021 (kr34.3 Mil) to Dec. 2022 (kr34.0 Mil) but then increased from Dec. 2022 (kr34.0 Mil) to Dec. 2023 (kr48.9 Mil).

Orexo AB Other Long Term Assets Historical Data

The historical data trend for Orexo AB's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orexo AB Other Long Term Assets Chart

Orexo AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 86.90 33.50 34.30 34.00 48.90

Orexo AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.00 48.90 51.70 54.00 50.40

Orexo AB Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Orexo AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orexo AB (OSTO:ORX) » Definitions » Other Long Term Assets
Comparable Companies
OSTO:MOB OSTO:DICOT OSTO:ENZY OSTO:NANEXA OSTO:CINPHA OSTO:ERMA OSTO:TOL OSTO:VIVE XSAT:ACUC OSTO:NEWBRY ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XTAE:TEVA NSE:DIVISLAB XSWX:SDZ VTRS
Traded in Other Exchanges
ORXOY:USA ORXOF:USA C5G:Germany
Address
Virdings alle 32 A, P.O. Box 303, Uppsala, SWE, 75105
Website
https://www.orexo.com
Orexo AB has operations in Sweden and the United States. Operations are monitored and presented in the segments USA Pharma, Digital Therapeutics (DTx), and HQ & Pipeline. The majority is from the USA Pharma segment. Geographically, the majority is derived from the United States. USA Pharma includes the commercialization of fully owned pharmaceuticals in the United States market. Digital Therapeutics include the commercialization of Orexo's groundbreaking evidence-based digital therapeutics, mainly in the United States market, which is in an early development stage. HQ &Pipeline includes the Development of pharmaceuticals performed at Orexo's headquarters in Uppsala, Sweden.

Orexo AB Headlines

No Headlines